PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Dave Schulte to join McKesson Ventures as MD

McKesson Ventures, the venture capital arm of McKesson Corporation, today announced that

Dave Schulte (pictured) has been appointed managing director of McKeeson Ventures, the venture capital arm of McKeeson Corporation, effective 8 September, 2015.
 
Schulte joins McKesson from Kaiser Permanente Ventures where he served as vice president and managing director. In his role at McKesson, Schulte will be responsible for co-leading the development and management of the McKesson Ventures portfolio alongside group leader Tom Rodgers.
 
McKesson Ventures, established in December 2014, has made minority investments in Carena, a telemedicine provider; Accolade, a concierge health care navigation and employee health engagement platform; PipelineRx, a technology and services platform company focused on telepharmacy, and Rock Health’s seed fund, among others. The fund targets companies that are both enabling and benefitting from disruptive changes affecting the health care industry, including increasing consumerism, emergence of alternate delivery models and the shift towards value based care.
 
“Dave is a well-respected, active investor in the areas of health care where we are focused and adding him to the team will help us continue to grow the fund and develop our portfolio,” says Tom Rodgers, senior vice president and managing director, McKesson Ventures. “At Kaiser Permanente, he demonstrated how a strategic investor can optimise its partnership with early stage companies to build value for both sides.”
 
Schulte has more than 17 years of experience as an investor and investment banker, partnering with entrepreneurs to grow innovative health care and technology businesses. He joined Kaiser Permanente Ventures in 2003 and helped build the investment program from USD20 million to USD400 million of assets under management. Schulte led Kaiser Permanente Ventures’ investment team, whose IT and Digital Health investments include: Ginger.io, Health Catalyst, Ingenious Med, KitCheck, MetricStream, Omada Health, Proteus Digital Health, Validic, and Rock Health’s seed fund.
Prior to KP Ventures, Schulte was a software and health care investment banker at JP Morgan (Hambrecht & Quist), UBS, and Piper Jaffray. He is a graduate of St. John's University and earned a Master of Public Policy degree from Harvard University.

Like this article? Sign up to our free newsletter

FEATURED

MOST RECENT

FURTHER READING